Three randomized trials have tested Eriomins effects on GLP-1 levels in people with prediabetes or type 2 diabetes
The program begins on Wednesday, July 1, 2026 and goes until December 31, 2027
Trina Wilcox: So, when muscle loss does occur for some of the patients who take the GLP-1s, is there any way to mitigate that with nutrition, or is there something they should be doing or completely go off
While it is still unclear as to what may cause a person taking a GLP-1 medication to experience an eye issue, researchers hypothesize that rapid changes in blood sugar levels might contribute to these eye complications
We know that weight can influence both symptoms and treatment outcomes in inflammatory arthritis, but the data about weight loss, and specifically GLP-1s, is a little bit more limited
Need help from an expert